I cannot for the life of me see how ANYBODY can put a fundamental share value on MBP. It is all based on smoke and mirrors at the moment. They have not earned a cent, and as they cannot manufacture or distribute any of the drugs themselves, then any valuation of their shares HAS to take into account whatever deal they can do with a pharmaceutical major. To try and value their shares on anything else is pure guesswork and optimism.
That's why I think the Cohen report is pure ramping, nothing less.
I don't hold MBP.
- Forums
- ASX - By Stock
- MBP
- information on mbp-- see website:
information on mbp-- see website:, page-5
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)